Assertion: targeted drug | /r/HasProperty | ~7%
Facets:
Source sentences:
text: Ongoing clinical trials are evaluating the potential of repurposing 23 (5%) of the approved GPCR-targeted drugs, which account for ~8%, ~7% and ~14% of the agent–indication pairs in phase I, II and III trials, respectively (Fig.